首页> 外国专利> SURGERY TECHNIQUE FOR JUVENILE NASOPHARYNGEAL ANGIOFIBROMA, INCLUDING EXTENDED INTO NASAL CAVITY AND BASILAR SINUS

SURGERY TECHNIQUE FOR JUVENILE NASOPHARYNGEAL ANGIOFIBROMA, INCLUDING EXTENDED INTO NASAL CAVITY AND BASILAR SINUS

机译:少年鼻咽血管纤维瘤的手术技术,包括扩展到鼻腔和基底窦

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine area, namely to otorhinolaryngology and can be used in practical surgery for treating juvenile angiofibroma. Substance of the technique implies the preoperative comprehensive examination of a patient to determine extension and nature of juvenile angiofibroma to be removed from access through maxillary sinus and nasal cavity. Herewith, 3-4 days prior to the surgery, endovascular occlusion of maxillary artery is performed. After general anesthesia followed by tracheal intubation and provided artificial pulmonary ventilation, 5-10 minutes prior to the surgery, blood exfusion in amount 0.5-1.5 litres is combined with crystalloid infusion in amount 0.5-1.5 litres to level the arterial pressure to 100-110/60-70. Transitory fold of upper lip is incised. After haemostasis, facial wall of maxillary sinus and piriform opening are uncovered. Maxillary sinus is open within canine fossa to remove maxillary frontal process, nasal bone, lacrimal bone and nasal process of frontal bone with making an access to angiofibroma and uncovering angiofibroma located in maxillary sinus and nasal cavity. A mouth-gag is established, and fixed angiofibroma is stripped with a surgeon's finger and a big round bone scraper. Total separation of angiofibroma from nasopharyngeal roof is followed with dislocation of the whole mass of moving angiofibroma into trepanation cavity with ovum forceps and complete removal thereof. Haemostasis of surgical area and posterior nasal packing are performed to introduce a tampon into maxillary sinus. Transitory fold mucosa of upper lip is sutured. Then the surgery termination stage involves complete reinfusion of a patient's autoblood.;EFFECT: application of the given invention allows for considerably reduced intraoperative haemorrhage, and for visual access to angiofibroma to be removed and inspection of trepanation cavity to evidence radical removal of total volume of angiofibroma.;3 ex, 2 cl
机译:领域:药物:本发明涉及医学领域,即耳鼻喉科,可用于治疗少年血管纤维瘤的实际手术中。该技术的实质意味着对患者进行术前全面检查,以确定将通过上颌窦和鼻腔切除的少年血管纤维瘤的范围和性质。因此,在手术前3-4天,进行上颌动脉的血管内闭塞。全身麻醉后气管插管并提供人工肺通气,在手术前5-10分钟,将0.5-1.5升的血液与0.5-1.5升的晶体注射相结合,以将动脉压调节至100-110 / 60-70。切开上唇的颞折。止血后,未发现上颌窦的面部壁和梨状开口。上颌窦在犬窝内开放,以去除上颌窦额叶,鼻骨,泪骨和额叶鼻梁,并进入血管纤维瘤并揭露位于上颌窦和鼻腔的血管纤维瘤。建立了漱口器,并用外科医生的手指和一个大的圆形骨刮刀剥离了固定的血管纤维瘤。将血管纤维瘤从鼻咽顶部完全分离,然后用卵子钳将全部移动的血管纤维瘤转移到带卵巢的腔中并完全清除。进行手术区域止血和后鼻填塞以将棉塞引入上颌窦。缝合上唇的短暂性折叠粘膜。然后,在手术终止阶段包括完全重新输注患者的自体血。效果:本发明的应用可大大减少术中出血,并可从视觉上清除血管纤维瘤并检查inspection腔,以证明根治性切除了总体积。血管纤维瘤;; 3 ex,2 cl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号